Abstract
Purpose
To investigate any association between post-transplantation anemia (PTA) and clinical outcomes following living donor kidney transplantation.
Methods
We retrospectively evaluated 887 patients who received living donor kidney transplantations at our medical center between January 2006 and December 2012 to evaluate whether PTA, defined as serum hemoglobin (Hb) levels of <130 g/l in men and <120 g/l in women, at 12 months is associated with post-transplant outcomes, including graft function, death-censored graft survival, or patient survival.
Results
The prevalence of PTA at 1, 3, 6, and 12 months was 84.3, 39.5, 26.2, and 21.6 %, respectively. Donor age [hazard ratio (HR), 1.03; 95 % confidence interval (CI) 1.01–1.05] and acute rejection (HR 2.13; 95 % CI 1.28−3.54) were found to be independent risk factors for PTA at 12 months. Recipient age (HR 0.98; 95 % CI 0.95−1.00), pre-transplantation Hb levels (HR 0.99; 95 % CI 0.98−1.00), and estimated glomerular filtration rates (eGFRs) at 12 months (HR 0.96; 95 % CI 0.94−0.97) were found to confer slight protection against PTA at 12 months. PTA at 12 months was associated with increased graft loss (HR 1.046; 95 % CI 1.045−1.046). For each increase in anemia degree, there was a 2.77-fold greater risk of graft loss (HR 2.77; 95 % CI 1.50−5.13). When stratified according to eGFR, PTA was found to be a predictor of graft loss in patients with an eGFR of <60 ml/min/1.73 m2 (HR 4.57; 95 % CI 1.98−10.56) but not in patients with an eGFR of >60 ml/min/1.73 m2 (HR 1.89; 95 % CI 0.13−27.78). PTA was not found to be a predictor of patient survival.
Conclusions
Anemia is common after kidney transplantation, and its prevalence declines with time after transplantation. Presence of anemia at 12 months post-transplant was an independent predictor of graft loss, with higher risk of graft loss in patients with anemia and poorer kidney functions.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11255-015-1069-y/MediaObjects/11255_2015_1069_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11255-015-1069-y/MediaObjects/11255_2015_1069_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11255-015-1069-y/MediaObjects/11255_2015_1069_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11255-015-1069-y/MediaObjects/11255_2015_1069_Fig4_HTML.gif)
Similar content being viewed by others
![](https://media.springernature.com/w215h120/springer-static/image/art%3Aplaceholder%2Fimages/placeholder-figure-springernature.png)
References
Lorenz M, Kletzmayr J, Perschl A et al (2002) Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 13(3):794–797
Molnar MZ, Novak M, Ambrus C et al (2005) Anemia in kidney transplanted patients. Clin Transplant 19(6):825–833
Montanaro D (2007) Anemia after renal transplantation. G Ital Nefrol 24(1):13–22
Chadban SJ, Baines L, Polkinghorne K et al (2007) Anemia after kidney transplantation is not completely explained by reduced kidney function. Am J Kidney Dis 49:301–309
Khosroshahi HT, Asghari A, Estakhr R et al (2006) Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients. Transplant Proc 38:2077–2079
Thaunat O, Beaumont C, Chatenoud L et al (2005) Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state. Transplantation 80:1212–1219
Vanrenterghem Y, Ponticelli C, Morales JM et al (2003) Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 3:835–845
Ersoy A, Kahvecioglu S, Ersoy C et al (2005) Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis. Transplant Proc 37:2148–2150
Blosser CD, Bloom RD (2010) Posttransplant anemia in solid organ recipients. Transplant Rev (Orlando) 24:89–98
Sarnak MJ, Tighiouart H, Manjunath G et al (2002) Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol 40:27–33
Herzog CA, Muster HA, Li S, Collins AJ (2004) Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the medicare population. J Card Fail 10:467–472
McClellan WM, Flanders WD, Langston RD et al (2002) Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 13(7):1928–1936
Weiner DE, Tighiouart H, Vlagopoulos PT (2005) Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol 16:1803–1810
Silverberg DS, Wexler D, Iaina A et al (2006) The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin Nephrol 26(4):296–306
Zalunardo N, Levin A (2006) Anemia and the heart in chronic kidney disease. Semin Nephrol 26(4):290–295
Foley RN, Parfrey PS, Harnett JD et al (1996) The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61
Imoagene-Oyedeji AE, Rosas SE, Doyle AM et al (2006) Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol 17:3240–3247
Chhabra D, Grafals M, Skaro AI et al (2008) Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection. Clin J Am Soc Nephrol 3(4):1168–1174
Gheith O, Wafa E, Hassan N et al (2009) Does posttransplant anemia at 6 months affect long-term outcome of live-donor kidney transplantation? a single center experience. Clin Exp Nephrol 13(4):361–366
Vanrenterghem YF, Claes K, Montagnino G et al (2008) Risk factors for cardiovascular events after successful renal transplantation. Transplantation 85:209–216
Kamar N, Rostaing L, Ignace S et al (2012) Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis. Clin Transplant 26:461–469
Pascual J, Jiménez C, Franco A et al (2013) Early onset anemia after kidney transplantation is an independent factor for graft loss: a multicenter, observational cohort study. Transplantation 96(8):717–725
Jones H, Talwar M, Nogueira JM et al (2012) Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis. Transplantation 93(9):923–928
Mix TC, Kazmi W, Khan S et al (2003) Anemia: a continuing problem following kidney transplantation. Am J Transplant 3:1426–1433
Yorgin PD, Scandling JD, Belson A et al (2002) Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem? Am J Transplant 2:429–435
Donnelly S (2001) Why is erythropoietin made in the kidney? The kidney functions as a critmeter. Am J Kidney Dis 38:415–425
Winkelmayer WC, Chandraker A (2008) Posttransplantation anemia: management and rationale. Clin J Am Soc Nephrol 3:S49–S55
Besarab A, Caro J, Jarrell BE et al (1987) Dynamics of erythropoiesis following renal transplantation. Kidney Int 32:526–536
Vanrenterghem Y (2009) Anemia after kidney transplantation. Transplantation 87(9):1265–1267
Molnar MZ, Czira M, Ambrus C et al (2007) Anemia is associated with mortality in kidney-transplanted patients—a prospective cohort study. Am J Transplant 7(4):818–824
de Andrade LG, Abrão JM, Carvalho MF (2012) Anemia at one year is an independent risk factor of graft survival. Int Urol Nephrol 44(1):263–268
Winkelmayer WC, Lorenz M, Kramar R et al (2004) Percentage of hypochromic red blood cells is and independent risk factor for mortality in kidney transplant recipients. Am J Transplant 4(12):2075–2081
Winkelmayer WC, Chandraker A, Alan Brookhart M et al (2006) A prospective study of aneamia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant 21(12):3559–3566
Kamar N, Rostaing L, Ignace S et al (2012) Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis. Clin Transplant 26(3):461–469
Schnitzler MA, Johnston K, Axelrod D et al (2011) Association of renal function 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs. Transplantation 91(12):1347–1356
Levin A (2002) Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl 80:35–38
Chang JM, Chen SC, Huang JC et al (2014) Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease. Am J Med Sci 347(3):183–189
Garrigue V, Szwarc I, Giral M et al (2014) Influence of anemia on patient and graft survival after renal transplantation: results from the French DIVAT cohort. Transplantation 97(2):168–175
Acknowledgments
This project was supported by the National Science Foundation of China (Grant Nos. 30872579 and 81470980).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare no conflicts of interest.
Additional information
Zhongli Huang and Turun Song are co-first authors.
Rights and permissions
About this article
Cite this article
Huang, Z., Song, T., Fu, L. et al. Post-renal transplantation anemia at 12 months: prevalence, risk factors, and impact on clinical outcomes. Int Urol Nephrol 47, 1577–1585 (2015). https://doi.org/10.1007/s11255-015-1069-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-015-1069-y